Implementing novel approaches for cancer therapy are under continuous progress, and bioactive glasses (BGs) and glass-ceramics show excellent potential in this regard. Although these materials have been mostly used as magnetic substances in hyperthermia approach, some of their subsets, i.e., mesoporous bioactive glasses (MBGs), have been recently proposed not only as magnetic materials but also as drug delivery systems for advanced treatment of bone cancer. Different types of MBGs including granular particles and three-dimensional (3D) scaffolds can be applied for cancer therapy. Based on the results obtained from in vitro studies, MBGs seem to have a bright future in the therapeutic strategies to combat cancer; however, their application in this field is still in its beginning, and more research needs to reveal all pros and cons of this newly proposed approach.
Mesoporous bioactive glasses (MBGs) in cancer therapy: Full of hope and promise / Kargozar, S.; Mozafari, M.; Hamzehlou, S.; Kim, H. -W.; Baino, F.. - In: MATERIALS LETTERS. - ISSN 0167-577X. - ELETTRONICO. - 251:(2019), pp. 241-246. [10.1016/j.matlet.2019.05.019]
Mesoporous bioactive glasses (MBGs) in cancer therapy: Full of hope and promise
Baino F.
2019
Abstract
Implementing novel approaches for cancer therapy are under continuous progress, and bioactive glasses (BGs) and glass-ceramics show excellent potential in this regard. Although these materials have been mostly used as magnetic substances in hyperthermia approach, some of their subsets, i.e., mesoporous bioactive glasses (MBGs), have been recently proposed not only as magnetic materials but also as drug delivery systems for advanced treatment of bone cancer. Different types of MBGs including granular particles and three-dimensional (3D) scaffolds can be applied for cancer therapy. Based on the results obtained from in vitro studies, MBGs seem to have a bright future in the therapeutic strategies to combat cancer; however, their application in this field is still in its beginning, and more research needs to reveal all pros and cons of this newly proposed approach.File | Dimensione | Formato | |
---|---|---|---|
MBG-cancer_Mater Letter 2019.pdf
non disponibili
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Non Pubblico - Accesso privato/ristretto
Dimensione
1.21 MB
Formato
Adobe PDF
|
1.21 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
MBGs and Cancer_R1_post-print.pdf
Open Access dal 07/05/2021
Tipologia:
2. Post-print / Author's Accepted Manuscript
Licenza:
Creative commons
Dimensione
4.18 MB
Formato
Adobe PDF
|
4.18 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11583/2743281
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo